INNOVATE BIOPHARMACEUTICALS, INC. License Agreements
6 Contracts & Agreements
- Exclusive License Agreement between 9 Meters Biopharma, Inc. and EBRIS srl (Filed With SEC on August 15, 2022)
- Amended and Restated License Agreement, dated May 1, 2020, between Amunix Pharmaceuticals, Inc. and Naia Rare Diseases, Inc (Filed With SEC on August 13, 2020)
- Second Amended and Restated License Agreement, dated May 1, 2020, between Amunix Pharmaceuticals, Inc. and Naia Rare Diseases, Inc (Filed With SEC on August 13, 2020)
- Amended and Restated Exclusive License Agreement, dated February 10, 2020, between Cedars-Sinai Medical Center and Naia Rare Diseases, Inc (Filed With SEC on August 13, 2020)
- Apaza License Agreement, dated April 19, 2013, between Innovate Biopharmaceuticals Inc. (now IB Pharmaceuticals Inc.) and Seachaid Pharmaceuticals, Inc., as amended (Filed With SEC on March 14, 2018)
- License Agreement, dated February 26, 2016, between Innovate Biopharmaceuticals Inc. (now IB Pharmaceuticals Inc.) and Alba Therapeutics Corporation (Filed With SEC on March 14, 2018)
